These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
284 related articles for article (PubMed ID: 8871601)
21. CS-A therapy in MRL-lpr/lpr mice: amelioration of immunopathology despite autoantibody production. Mountz JD; Smith HR; Wilder RL; Reeves JP; Steinberg AD J Immunol; 1987 Jan; 138(1):157-63. PubMed ID: 3537128 [TBL] [Abstract][Full Text] [Related]
22. Plasma levels of nucleosomes and nucleosome-autoantibody complexes in murine lupus: effects of disease progression and lipopolyssacharide administration. Licht R; van Bruggen MC; Oppers-Walgreen B; Rijke TP; Berden JH Arthritis Rheum; 2001 Jun; 44(6):1320-30. PubMed ID: 11407691 [TBL] [Abstract][Full Text] [Related]
23. Vaccination with autoreactive CD4(+)Th1 clones in lupus-prone MRL/Mp-Fas(lpr/lpr) mice. Fujii T; Okada M; Fujita Y; Sato T; Tanaka M; Usui T; Umehara H; Mimori T J Autoimmun; 2009 Sep; 33(2):125-34. PubMed ID: 19596182 [TBL] [Abstract][Full Text] [Related]
24. IL-12-encoding plasmid has a beneficial effect on spontaneous autoimmune disease in MRL/MP-lpr/lpr mice. Hagiwara E; Okubo T; Aoki I; Ohno S; Tsuji T; Ihata A; Ueda A; Shirai A; Okuda K; Miyazaki J; Ishigatsubo Y Cytokine; 2000 Jul; 12(7):1035-41. PubMed ID: 10880249 [TBL] [Abstract][Full Text] [Related]
25. Effects of oral administration of malathion on the course of disease in MRL-lpr mice. Rodgers KE J Autoimmun; 1997 Aug; 10(4):367-73. PubMed ID: 9237800 [TBL] [Abstract][Full Text] [Related]
40. Mouse complement receptors type 1 (CR1;CD35) and type 2 (CR2;CD21): expression on normal B cell subpopulations and decreased levels during the development of autoimmunity in MRL/lpr mice. Takahashi K; Kozono Y; Waldschmidt TJ; Berthiaume D; Quigg RJ; Baron A; Holers VM J Immunol; 1997 Aug; 159(3):1557-69. PubMed ID: 9233655 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]